Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia
Objective Use of oral short-acting beta 2-agonist (SABA) persists in non-resource poor countries despite concerns for its lower efficacy and safety. Utilisation and reasons for such use is needed to support the effort to discourage the use of oral SABA in asthma. This study examined the frequency of...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Public Library of Science
2017
|
| Subjects: |